GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.18 Cr | ₹-0.23 Cr | ₹-0.14 Cr | ₹0.00 Cr | ₹0.15 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GENNEX LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.18 Cr |
| Mar2024 | ₹-0.23 Cr |
| Mar2023 | ₹-0.14 Cr |
| Mar2022 | ₹0.00 Cr |
| Mar2021 | ₹0.15 Cr |
How is Deferred Tax Assets / Liabilities of GENNEX LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.18 Cr | Negative | |
| Mar2024 | ₹-0.23 Cr | Negative | |
| Mar2023 | ₹-0.14 Cr | Negative | |
| Mar2022 | ₹0.00 Cr | -98.04 | |
| Mar2021 | ₹0.15 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹259.9 Cr | 2.5% | -12.8% | -14.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,148.0 Cr | 2.6% | 1.2% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,009.0 Cr | 1.3% | -2.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,779.0 Cr | 1.5% | 0.7% | 37.1% | Stock Analytics | |
| CIPLA | ₹115,772.0 Cr | 6.1% | 2.4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,616.0 Cr | 2.6% | -0.4% | -2.1% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | 2.5% |
-12.8% |
-14.1% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses